Agios Pharmaceuticals | AGIO - 资产



金融业
股票价格
USD
资产
USD 1.18B
现金及等价物
USD 113.6M
销售成本
USD 1.32M
流动资产
USD 834.84M
流动负债
USD 58.85M
债务
USD 40.21M
EBIT
USD -110.03M
EBITDA
USD -120.31M
员工
486
EPS每股收益
USD -1.69
股本和储备
USD 1.11B
销售毛利
USD 19.43M
债务利息支出
USD 1.18B
利息收入
USD 12.41M
贷款资金
USD 1.06M
市值
USD 2.26B
净收入
USD -99.11M
营业费用
USD 130.77M
营业利润
USD -110.03M
普通股股本
USD 59.34M
PE价格收益
3.56
税前利润
USD -99.11M
销售收入
USD 18.8M
销售和管理费用
USD 38.46M
股票
USD 35.09M
贸易债权人
USD 13.75M
应收帐款人
USD 16.13M


资产 更改 日
AbbVie USD 136.46B 2.5B 2026-03
Agios Pharmaceuticals USD 1.18B 112.24M 2026-03
Alnylam Pharmaceuticals USD 5.13B 163.22M 2026-03
Amgen USD 92.5B 1.92B 2026-03
Arrowhead Research USD 2.27B 664.08M 2026-03
Astellas Pharma JPY 3.57T 36.87B 2026-03
AstraZeneca USD 114.02B 59M 2026-03
Bayer EUR 107.94B 3.4B 2026-03
Biogen USD 29.48B 43.6M 2026-03
BioMarin Pharmaceutical USD 8.59B 996.99M 2026-03
Bristol-Myers Squibb USD 86.48B 3.56B 2026-03
Daiichi Sankyo JPY 3.82T 252.52B 2025-12
Eli Lilly USD 116.58B 4.1B 2026-03
Exelixis USD 2.59B 250.83M 2026-03
Gilead Sciences USD 56.28B 2.74B 2026-03
GlaxoSmithKline GBP 62.87B 1.75B 2026-03
Incyte USD 7.34B 381.14M 2026-03
Ionis Pharmaceuticals USD 3.45B 74M 2026-03
Merck USD 128.68B 8.18B 2026-03
Moderna USD 11.49B 850M 2026-03
Nektar Therapeutics USD 280.41M 20.94M 2025-12
Novartis USD 118.53B 7.58B 2026-03
Novartis USD 118.53B 7.58B 2026-03
Pfizer USD 207.62B 542M 2026-03
Puma Biotechnology USD 202.86M 7.95M 2025-09
Regeneron Pharmaceuticals USD 40.87B 310.1M 2026-03
Roche Holding CHF 100.7B 5.94B 2025-12
Sarepta Therapeutics USD 3.18B 170.77M 2026-03
Vertex Pharmaceuticals USD 26.48B 841.4M 2026-03